141
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ten-Year Analysis of Pathogenic Factors and Etiological Characteristics of Endophthalmitis from a Tertiary Eye Center in North China

, , &
Pages 3005-3012 | Published online: 10 Jun 2022

References

  • Durand ML. Bacterial and fungal endophthalmitis. Clin Microbiol Rev. 2017;30(3):597–613. doi:10.1128/CMR.00113-16
  • Moloney TP, Park J. Microbiological isolates and antibiotic sensitivities in culture-proven endophthalmitis: a 15-year review. Br J Ophthalmol. 2014;98(11):1492–1497. doi:10.1136/bjophthalmol-2014-305030
  • Durand ML. Endophthalmitis. Clin Microbiol Infect. 2013;19(3):227–234. doi:10.1111/1469-0691.12118
  • Harper T, Miller D, Flynn HW. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology. 2007;114(5):871–875. doi:10.1016/j.ophtha.2007.01.007
  • Benz MS, Scott IU, Flynn HW, Unonius N, Miller D. Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am J Ophthalmol. 2004;137(1):38–42. doi:10.1016/S0002-9394(03)00896-1
  • Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn HW. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol. 2006;124(4):479–483. doi:10.1001/archopht.124.4.479
  • Chen R, Xie L, Sun S, Dong X. Clinical analysis of 282 patients with infections endophthalmitis. Chin J Ocul Fundus Dis. 2008;24(6):402–405.
  • Wan L, Chen N, Zhang J, Cheng J, Liu F, Xie L. Analysis of pathogenic factors and etiological characteristics of 531 patients with suppurative endophthalmitis. Chin J Ocul Fundus Dis. 2019;35(2):181–186.
  • Lin L, Mei F, Liao J, Yang Y, Duan F, Lin X. Nine-year analysis of isolated pathogens and antibiotic susceptibilities of infectious endophthalmitis from a large referral eye center in Southern China. Infect Drug Resist. 2020;13:493–500. doi:10.2147/IDR.S235954
  • Bhattacharjee H, Bhattacharjee K, Gogoi K, Singh M, Singla BG, Yadav A. Microbial profile of the vitreous aspirates in culture proven exogenous endophthalmitis: a 10-year retrospective study. Indian J Med Microbiol. 2016;34(2):153–158. doi:10.4103/0255-0857.180280
  • Sun J, Guo Z, Li H, Yang B, Wu X. Acute infectious endophthalmitis after cataract surgery: epidemiological characteristics, risk factors and incidence trends, 2008–2019. Infect Drug Resist. 2021;14:1231–1238. doi:10.2147/IDR.S304675
  • Fan C, Yang B, Huang Y. Efficacy of 0.5% levofloxacin and 5.0% povidone-iodine eyedrops in reducing conjunctival bacterial flora: metagenomic analysis. J Ophthalmol. 2020;2020:1780498. doi:10.1155/2020/1780498
  • Ma X, Xie L, Huang Y. Intraoperative cefuroxime irrigation prophylaxis for acute-onset endophthalmitis after phacoemulsification surgery. Infect Drug Resist. 2020;13:1455–1463.
  • Henry CR, Flynn HW, Miller D, Forster RK, Alfonso EC. Infectious keratitis progressing to endophthalmitis: a 15-year study of microbiology, associated factors, and clinical outcomes. Ophthalmology. 2012;119(12):2443–2449. doi:10.1016/j.ophtha.2012.06.030
  • Cunningham ET, Flynn HW, Relhan N, Zierhut M. Endogenous Endophthalmitis. Ocul Immunol Inflamm. 2018;26(4):491–495. doi:10.1080/09273948.2018.1466561
  • Danielescu C, Anton N, Stanca HT, Munteanu M. Endogenous endophthalmitis: a review of case series published between 2011 and 2020. J Ophthalmol. 2020;2020:8869590. doi:10.1155/2020/8869590
  • Liu C, Ji J, Li S, et al. Microbiological isolates and antibiotic susceptibilities: a 10-year review of culture-proven endophthalmitis cases. Curr Eye Res. 2017;42(3):443–447. doi:10.1080/02713683.2016.1188118
  • Slean GR, Shorstein NH, Liu L, Paschal JF, Winthrop KL, Herrinton LJ. Pathogens and antibiotic sensitivities in endophthalmitis. Clin Exp Ophthalmol. 2017;45(5):481–488. doi:10.1111/ceo.12910
  • Liu C, Ji J, Wang Z, Chen H, Cao W, Sun X. Microbiological isolates and antibiotic susceptibilities in cases of posttraumatic endophthalmitis: a 15-year review. J Ophthalmol. 2020;2020:5053923. doi:10.1155/2020/5053923
  • Yang Y, Lin L, Li Y, et al. Etiology, microbiological isolates, and antibiotic susceptibilities in culture-proven pediatric endophthalmitis: a 9-year review. Graefes Arch Clin Exp Ophthalmol. 2021;259(1):197–204. doi:10.1007/s00417-020-04866-7
  • Pathengay A, Moreker MR, Puthussery R, et al. Clinical and microbiologic review of culture-proven endophthalmitis caused by multidrug-resistant bacteria in patients seen at a tertiary eye care center in southern India. Retina. 2011;31(9):1806–1811. doi:10.1097/IAE.0b013e31820f4b9d
  • Carifi G, Zygoura V, Pitsas C, Kopsachilis N. Endophthalmitis isolates and antibiotic susceptibilities: a 10-year review of culture-proven cases. Am J Ophthalmol. 2013;156(6):1321–1322. doi:10.1016/j.ajo.2013.09.007
  • Zapp D, Loos D, Feucht N, et al. Microbial keratitis-induced endophthalmitis: incidence, symptoms, therapy, visual prognosis and outcomes. BMC Ophthalmol. 2018;18(1):112–118. doi:10.1186/s12886-018-0777-3
  • Dhirachaikulpanich D, Soraprajum K, Boonsopon S, et al. Epidemiology of keratitis/scleritis-related endophthalmitis in a university hospital in Thailand. Sci Rep. 2021;11(1):11217–11223. doi:10.1038/s41598-021-90815-1
  • Shi W, Wang T, Xie L, et al. Risk factors, clinical features, and outcomes of recurrent fungal keratitis after corneal transplantation. Ophthalmology. 2010;117(5):890–896. doi:10.1016/j.ophtha.2009.10.004
  • Xie L, Zhai H, Shi W, Zhao J, Sun S, Zang X. Hyphal growth patterns and recurrence of fungal keratitis after lamellar keratoplasty. Ophthalmology. 2008;115(6):983–987. doi:10.1016/j.ophtha.2007.07.034
  • Safneck JR. Endophthalmitis: a review of recent trends. Saudi J Ophthalmol. 2012;26(2):181–189. doi:10.1016/j.sjopt.2012.02.011
  • Gentile RC, Shukla S, Shah M, et al. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology. 2014;121(8):1634–1642. doi:10.1016/j.ophtha.2014.02.001
  • Cannas S, Usai D, Pinna A, et al. Essential oils in ocular pathology: an experimental study. J Infect Dev Ctries. 2015;9(6):650–654. doi:10.3855/jidc.6842
  • Tognetto D, Pastore MR, Belfanti L, et al. In vivo antimicrobial activity of 0.6% povidone-iodine eye drops in patients undergoing intravitreal injections: a prospective study. Sci Rep. 2021;11(1):23271–23276. doi:10.1038/s41598-021-02831-w
  • Pinna A, Donadu MG, Usai D, Dore S, Boscia F, Zanetti S. In vitro antimicrobial activity of a new ophthalmic solution containing hexamidine diisethionate 0.05% (keratosept). Cornea. 2020;39(11):1415–1418. doi:10.1097/ICO.0000000000002375